VaccinesHaving the disease or getting vaccinated—which provides more immunity?
Sources: 8 · Article: 10 278 characters
The STOP NOP Association states that immunity after whooping cough can last from 4 to 20 years, while immunity after vaccination against the disease wanes within two years.
- According to the association, having rubella provides lifelong immunity, while vaccination does not.
- Prof. Sucharit Bhakdi says that respiratory infections stimulate antibodies on the mucous membranes, which prevent infections only to a limited extent.
- He adds that a vaccine can protect against serious symptoms, even if it does not prevent infection.
What the authors write
Stowarzyszenie STOP NOP
Vaccines can provide only temporary immunity, and sometimes do not protect against infection.
„VACCINES: LEARN ABOUT THEIR INEFFECTIVENESS
Vaccines can provide temporary immunity, but sometimes they do not even provide temporary protection against infection for some people. Three examples of such vaccines are those against whooping cough, influenza, and mumps.”SZCZEPIENIA: POZNAJ ICH NIESKUTECZNOŚĆ
Szczepionki mogą zapewniać czasową odporność, jednak czasem nie zapewniają poszczególnym osobom nawet czasowej ochrony przez zakażeniem. Trzema przykładami takich szczepionek są szczepionki przeciwko krztuścowi, grypie i śwince.
Stowarzyszenie STOP NOP
After whooping cough, immunity can last from 4 to 20 years.
„The CDC states: “If your doctor confirms that you have whooping cough, your body will have a natural barrier (immunity) against future infections. Some observational studies suggest that whooping cough infection provides immunity for 4–20 years.”37”CDC stwierdza ?Jeśli lekarz potwierdzi zachorowanie na krztusiec, w organizmie osoby chorej występować będzie naturalna bariera (odporność) w przypadku przyszłych zakażeń. Niektóre badania obserwacyjne wskazują, że zakażenie krztuścem zapewnia odporność na 4-20 lat.?37
Stowarzyszenie STOP NOP
Immunity after vaccination against whooping cough wanes within two years.
„“The number of people vaccinated with vaccines containing whooping cough [is high],” although immunity acquired through vaccination wanes within two years of vaccination. Natural immunity to whooping cough acquired through infection also provides immunity. The CDC states: “If your doctor confirms that you have whooping cough, your body will have a natural barrier (immunity) against future infections.””szczepionkami zawierającymi krztusiec ?jest duża?, choć odporność nabyta wskute szczepienia zanika w ciągu dwóch lat od szczepienia. Naturalna odporność na krztusiec nabyta wskutek zakażenia również daje odporność. CDC stwierdza ?Jeśli lekarz potwierdzi zachorowanie na krztusiec, w organizmie osoby chorej występować będzie naturalna bariera (odporność) w przypadku przyszłych zakażeń.
Stowarzyszenie STOP NOP
According to the STOP NOP Association, having rubella provides lifelong immunity, while vaccination does not.
„Acquiring immunity through disease:
Having the disease provides lifelong immunity.
Immunity after vaccination:
Vaccination against rubella does not provide lifelong immunity. Vaccinating girls in childhood reduces their chance of naturally getting rubella, and therefore ?”Nabycie odporności po chorobie:
Przebycie choroby daje dożywotnią odporność.
Odporność po szczepieniu:
Zaszczepienie przeciwko różyczce nie daje dożywotniej odporności. Szczepienie dziewczynek w dzieciństwie zmniejsza ich szansę na naturalne przechorowanie różyczki, a tym samym ?
Prof. Sucharit Bhakdi
Natural respiratory infection stimulates antibodies on the mucous membranes; a vaccine administered through the nose may do this, but is described as experimental.
„The only thing that will effectively induce secretory IgA antibodies (sIgA) are naturally occurring airway infections, or possibly intranasally applied vaccines, which however so far are experimental [39].5 The mucous membranes of healthy individuals are consequently coated with antibodies directed against common respiratory viruses.”The only thing that will effectively induce secretory IgA antibodies (sIgA) are naturally occurring airway infections, or possibly intranasally applied vaccines, which however so far are experimental [39].5 The mucous membranes of healthy individuals are consequently coated with antibodies directed against common respiratory viruses.
Prof. Sucharit Bhakdi
Antibodies on the mucous membranes prevent infections only to a limited extent, which is why infections with airborne viruses can recur throughout life.
„The only thing that will effectively induce secretory IgA antibodies (sIgA) are naturally occurring airway infections, or possibly intranasally applied vaccines, which however so far are experimental [39].5 The mucous membranes of healthy individuals are consequently coated with antibodies directed against common respiratory viruses. However, the capacity of these antibodies to prevent infections is limited, which is why infections with air-borne viruses occur repeatedly throughout life.”The only thing that will effectively induce secretory IgA antibodies (sIgA) are naturally occurring airway infections, or possibly intranasally applied vaccines, which however so far are experimental [39].5 The mucous membranes of healthy individuals are consequently coated with antibodies directed against common respiratory viruses. However, the capacity of these antibodies to prevent infections is limited, which is why infections with air-borne viruses occur repeatedly throughout life.
Prof. Sucharit Bhakdi
A vaccine can protect against serious symptoms of a disease, even if it does not prevent infection.
„A vaccine that does not suppress infection may still protect from significant clinical disease. For example, poliovirus initially infects the mucous membranes of the gut, and it is from there that the virus is shed and propagated. However, this intestinal infection amounts to no more than an episode of diarrhea.”A vaccine that does not suppress infection may still protect from significant clinical disease. For example, poliovirus initially infects the mucous membranes of the gut, and it is from there that the virus is shed and propagated. However, this intestinal infection amounts to no more than an episode of diarrhea.
Research from PubMed · Europe PMC
We selected 2 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 24 510.
In the first week, the antibody response was stronger after infection, but from the second week to the sixth month, no significant difference was found between infected and vaccinated people.
Aim of the study: The COVID-19 pandemic has caused a large mortality and morbidity burden globally. For individuals, a strong immune response is the most effective means to block SARS-CoV-2 infection. To inform clinical case management of COVID-19, development of improved vaccines, and public health policy, a better understanding of antibody response dynamics and duration following SARS-CoV-2 infection and after vaccination is imperatively needed.
Results: The meta-analysis showed that within the first week after COVID-19 symptom onset/diagnosis or vaccination, antibody response rates in vaccinated individuals were lower than those in infected patients (p < 0.01), but no significant difference was observed from the second week to the sixth month. IgG, IgA, and IgM positivity rates increased during the first 3 weeks; thereafter, IgG positivity rates were maintained at a relatively high level, while the IgM seroconversion rate dropped. Antibody production following vaccination might not occur as quickly or strongly as after natural infection, and the IgM antibody response was less persistent than the IgG response.
Money for the studycompany together with others · Ruprecht-Karls-Universität Heidelberg, Chinese Academy of Medical Sciences & Peking Union Medical College, EU Horizon Europe
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studycombined analysis of many studies (meta-analysis)
“Not stated” does not mean nobody paid — the database does not always record it.
The review suggests that hybrid immunity after infection and vaccination may provide broader protection.
Aim of the study: Following infection and vaccination against SARS-CoV-2, humoral components of the adaptive immune system play a key role in protecting the host. Specifically, B cells generate high-affinity antibodies against various antigens of the virus.
Results: Cross-reactive immunity is under scrutiny as well, as pre-existing antibodies can offer protection against the disease. We also decipher breakthrough infection mechanisms, especially with the novel variants of the virus. Finally, we discuss some potential therapeutic solutions regarding B cells including convalescent plasma therapy, B-1 cells, B regulatory cell (Breg) modulation, and the use of neutralizing monoclonal antibodies in combating the infection. Ongoing research is crucial to grasp population immunity trends and assess the potential need for booster doses in maintaining effective immune responses against potential viral threats.
Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studydiscussion of other studies
“Not stated” does not mean nobody paid — the database does not always record it.
Perspectives and opinion materials
The content below presents the authors’ opinions, interpretations and hypotheses. It is not treated as equal to scientific studies and systematic reviews.
Orthomolecular Medicine News Service Opinion material
„Vaccination may protect from infection, but the infection is carried for longer than the unvaccinated. This would encourage spread of pertussis. This makes a nonsense of Big Pharma's advice to vaccinate all members of a new infant's family to protect the infant from infection This "cocooning" strategy increases the risk of infant infection. Herd immunity cannot apply to vaccines which afford protection against bacterial endotoxins and so herd immunity cannot possibly occur with tetanus and diphtheria vaccines. The spread of diphtheria has been controlled by isolating sufferers and treating them with antibiotics.”Vaccination may protect from infection, but the infection is carried for longer than the unvaccinated. This would encourage spread of pertussis. This makes a nonsense of Big Pharma's advice to vaccinate all members of a new infant's family to protect the infant from infection This "cocooning" strategy increases the risk of infant infection. Herd immunity cannot apply to vaccines which afford protection against bacterial endotoxins and so herd immunity cannot possibly occur with tetanus and diphtheria vaccines. The spread of diphtheria has been controlled by isolating sufferers and treating them with antibiotics.
Orthomolecular Medicine News Service Opinion material
„[5,6] Measles Before the development of vaccines for the childhood diseases of measles, rubella (German measles) mumps, chicken pox, and pertussis (or whopping cough), it was common, every spring, to have epidemics in any given locale of one or more of these diseases, so that usually before adulthood a person had acquired the long lasting immunity that the natural infection produces. Vaccines do not afford this degree of protection. The further we have gone down the road of vaccination, the further a "catch twenty-two" situation develops.”[5,6] Measles Before the development of vaccines for the childhood diseases of measles, rubella (German measles) mumps, chicken pox, and pertussis (or whopping cough), it was common, every spring, to have epidemics in any given locale of one or more of these diseases, so that usually before adulthood a person had acquired the long lasting immunity that the natural infection produces. Vaccines do not afford this degree of protection. The further we have gone down the road of vaccination, the further a "catch twenty-two" situation develops.
Orthomolecular Medicine News Service Opinion material
„A 2010 study suggested that natural immunity to whooping cough lasts at least 30 years,[2] whereas the immunity from a vaccine lasts three years at most.[3] Because of the limited duration of transient immunity after vaccination, B. pertussis boosters are now being recommended for 8-12 year-olds, adults, women during each pregnancy, and contacts of newborns before every birth. If you think that a vaccinated person cannot get whooping cough, in the most severe manner, think again. Most babies over the age of 6 months who get whooping cough are fully and "appropriately" vaccinated.”A 2010 study suggested that natural immunity to whooping cough lasts at least 30 years,[2] whereas the immunity from a vaccine lasts three years at most.[3] Because of the limited duration of transient immunity after vaccination, B. pertussis boosters are now being recommended for 8-12 year-olds, adults, women during each pregnancy, and contacts of newborns before every birth. If you think that a vaccinated person cannot get whooping cough, in the most severe manner, think again. Most babies over the age of 6 months who get whooping cough are fully and "appropriately" vaccinated.
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.